ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 167 filers reported holding ANI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 6.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $47,000 | -4.1% | 766 | +13.6% | 0.01% | +11.1% |
Q3 2019 | $49,000 | -10.9% | 674 | -18.1% | 0.01% | -30.8% |
Q2 2019 | $55,000 | +5.8% | 823 | +11.8% | 0.01% | +30.0% |
Q1 2019 | $52,000 | +57.6% | 736 | 0.0% | 0.01% | +42.9% |
Q4 2018 | $33,000 | -28.3% | 736 | -10.6% | 0.01% | -22.2% |
Q3 2018 | $46,000 | -14.8% | 823 | 0.0% | 0.01% | -25.0% |
Q2 2018 | $54,000 | +12.5% | 823 | 0.0% | 0.01% | +9.1% |
Q1 2018 | $48,000 | -14.3% | 823 | +30.8% | 0.01% | -15.4% |
Q4 2017 | $56,000 | – | 629 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |